RNA DISEASE DIAGNOSTICS

RNADD is developing a very low-cost molecular diagnostic testing platform for point-of-care diagnosis of infectious diseases to disrupt and democratize molecular testing. Our strategy is to leverage our proprietary Electrochemical and Antisense Oligonucleotide (ASO) molecular testing platform across multiple infectious disease categories including Women's Health, Respiratory Diseases (Covid-19, Flu A, RSV, Strep A), Sexually Transmitted Infections, and future Pandemics, etc... Our POC molecular diagnostic platform, based on our novel and proprietary ASO and electrochemical biosensor technology, provides multiplexed results in 5-minutes. We are developing several multiplexed panels for multiple Infectious Diseases.

Also known as: RNA Disease Diagnostics, Inc.